JY
HCAT icon

Jeff Yass’s Health Catalyst HCAT Stock Holding History

Jeff Yass’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.4K Sell
35,400
-700
-2% -$1.01K ﹤0.01% 12686
2026
Q1 		$45.8K Buy
+36,100
New +$67.9K ﹤0.01% 12658
2024
Q4 		– Sell
-11,600
Closed -$94.4K – 12609
2024
Q3 		$94.4K Buy
+11,600
New +$83.8K ﹤0.01% 11085
2022
Q4 		– Sell
-26,600
Closed -$258K – 12913
2022
Q3 		$258K Buy
26,600
+15,700
+144% +$208K ﹤0.01% 10189
2022
Q2 		$158K Buy
10,900
+3,200
+42% +$54.6K ﹤0.01% 10962
2022
Q1 		$201K Sell
7,700
-11,500
-60% -$326K ﹤0.01% 11225
2021
Q4 		$761K Sell
19,200
-64,600
-77% -$2.94M ﹤0.01% 8018
2021
Q3 		$4.19M Sell
83,800
-134,000
-62% -$7.31M ﹤0.01% 4262
2021
Q2 		$12.1M Buy
217,800
+138,900
+176% +$7.4M ﹤0.01% 2651
2021
Q1 		$3.69M Buy
78,900
+49,500
+168% +$2.4M ﹤0.01% 4513
2020
Q4 		$1.28M Sell
29,400
-23,400
-44% -$863K ﹤0.01% 6096
2020
Q3 		$1.93M Buy
52,800
+35,100
+198% +$1.19M ﹤0.01% 4688
2020
Q2 		$516K Buy
17,700
+7,200
+69% +$199K ﹤0.01% 7297
2020
Q1 		$275K Sell
10,500
-15,700
-60% -$480K ﹤0.01% 8144
2019
Q4 		$909K Buy
+26,200
New +$867K ﹤0.01% 5718

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's HCAT Position: Q2 2026 in Review

Jeff Yass increased its Health Catalyst (HCAT) stake by 439% in Q2 2026, buying an estimated $514K and bringing the position to 437,227 shares worth $870K. The position accounts for ﹤0.01% of the portfolio, ranked #8554.

Jeff Yass first reported a position in HCAT in Q1 2020 and has held it in 22 quarters since. The position peaked at $1.09M in Q3 2024. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Jeff Yass held 437,227 shares of Health Catalyst worth $870K as of Q2 2026.
  • Jeff Yass bought 356,073 Health Catalyst shares in Q2 2026, an estimated $514K.
  • Health Catalyst made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8554 holding.
  • Jeff Yass first reported a position in Health Catalyst in Q1 2020 and has held it in 22 quarters since.
  • Jeff Yass's Health Catalyst position peaked at $1.09M in Q3 2024.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.